Fate Therapeutics, Inc. (FATE)
2.09
-0.08
(-3.69%)
USD |
NASDAQ |
Oct 30, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Free Cash Flow : -105.66M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -105.66M |
| March 31, 2026 | -108.09M |
| December 31, 2025 | -112.04M |
| September 30, 2025 | -115.43M |
| June 30, 2025 | -118.76M |
| March 31, 2025 | -125.17M |
| December 31, 2024 | -123.60M |
| September 30, 2024 | -132.52M |
| June 30, 2024 | -141.45M |
| March 31, 2024 | -139.78M |
| December 31, 2023 | -138.42M |
| September 30, 2023 | -183.66M |
| June 30, 2023 | -208.55M |
| March 31, 2023 | -241.14M |
| December 31, 2022 | -283.77M |
| September 30, 2022 | -290.37M |
| June 30, 2022 | -274.76M |
| March 31, 2022 | -257.19M |
| December 31, 2021 | -213.57M |
| September 30, 2021 | -147.85M |
| June 30, 2021 | -131.42M |
| March 31, 2021 | -47.50M |
| December 31, 2020 | -44.16M |
| September 30, 2020 | -49.35M |
| June 30, 2020 | -38.76M |
| Date | Value |
|---|---|
| March 31, 2020 | -99.07M |
| December 31, 2019 | -90.57M |
| September 30, 2019 | -74.58M |
| June 30, 2019 | -57.76M |
| March 31, 2019 | -47.46M |
| December 31, 2018 | -40.95M |
| September 30, 2018 | -40.33M |
| June 30, 2018 | -46.27M |
| March 31, 2018 | -43.76M |
| December 31, 2017 | -38.63M |
| September 30, 2017 | -34.70M |
| June 30, 2017 | -32.03M |
| March 31, 2017 | -30.46M |
| December 31, 2016 | -30.28M |
| September 30, 2016 | -29.84M |
| June 30, 2016 | -30.07M |
| March 31, 2016 | -20.50M |
| December 31, 2015 | -19.90M |
| September 30, 2015 | -19.17M |
| June 30, 2015 | -17.09M |
| March 31, 2015 | -24.48M |
| December 31, 2014 | -23.30M |
| September 30, 2014 | -21.60M |
| June 30, 2014 | -19.39M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AVITA Medical, Inc. | -25.21M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 10.18B |
| Anika Therapeutics, Inc. | 0.562M |
| BioCryst Pharmaceuticals, Inc. | 356.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.43M |
| Cash from Investing (Quarterly) | 14.56M |
| Cash from Financing (Quarterly) | 1.736M |
| Free Cash Flow Per Share (Quarterly) | -0.1953 |
| Free Cash Flow to Equity (Quarterly) | -22.40M |
| Free Cash Flow to Firm (Quarterly) | -23.51M |
| Free Cash Flow Yield | -42.25% |